Clinical Trials · NCT03488810
Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Withdrawn
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Enrollment
- 0
- Start date
- Mar 2020
- Locations
- See registry
- Primary endpoint
- Disease-free survival